Updated
December 10, 2022
Investors who bought Ra Medical Systems (RMED) stock in or after its IPO shared in a $10 million recovery. The claim deadline has passed.
What's This Settlement About?
A class action settlement has been reached in order to settle a lawsuit against RA Medical Systems Inc and their publically traded stock, RMED listed on NASDAQ. The lawsuit stems from allegations that RA Medical made material misstatements and/or omitted material facts about RA Medical's operations, including product defects with DABRA catheters, product recall, off-label marketing of DABRA, and improper payments to physicians. Pursuant to the Settlement, Defendants have agreed to pay or cause to be paid $10,000,000 in cash.
Status
Claims Closed
Claim deadline passed July 9, 2022
Claim Deadline
July 9, 2022 (Passed)
Settlement Fund
$10,000,000
Cash · pro rata by recognized loss
Proof Required
Yes
Brokerage records of RMED trades
How Do I Qualify?
The Settlement Class consists of all persons and entities that purchased or otherwise acquired the common stock of RA Medical:• pursuant and/or traceable to RA Medical's IPO; and/or
• between September 27, 2018 and November 27, 2019, inclusive.
How Do I File a Claim?
To be eligible for a payment from the proceeds of the Settlement, you must have submitted a claim form online or postmarked no later than July 9, 2022.The Court held a hearing on June 13, 2022 at 11:30 a.m.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
